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Abstract 
 
Chronic traumatic encephalopathy (CTE) is a neurodegenerative disorder which may 
result from repetitive brain injury. A variety of tau-immunoreactive pathologies are 
present including neurofibrillary tangles (NFT), neuropil threads (NT), dot-like grains 
(DLG), astrocytic tangles (AT), and occasional neuritic plaques (NP). In tauopathies, 
cellular inclusions in the cortex are clustered within specific laminae, the clusters 
being regularly distributed parallel to the pia mater. To determine whether a similar 
spatial pattern is present in CTE, clustering of the tau-immunoreactive pathology was 
studied in the cortex, hippocampus, and dentate gyrus in eleven cases of CTE and 
seven cases of Alzheimer’s disease neuropathologic change (ADNC) without CTE. In 
CTE: (1) all aspects of tau-immunoreactive pathology were clustered and the clusters 
were frequently regularly distributed parallel to the tissue boundary, (2) clustering was 
similar in two CTE cases with minimal co-pathology compared with cases with 
associated ADNC or TDP-43 proteinopathy, (3) in a proportion of cortical gyri, 
estimated cluster size was similar to that of cell columns of the cortico-cortical 
pathways, and (4) clusters of the tau-immunoreactive pathology were infrequently 
spatially correlated with blood vessels. The NFT and NP in ADNC without CTE were 
less frequently randomly or uniformly distributed and more frequently in defined 
clusters than in CTE. Hence, the spatial pattern of the tau-immunoreactive pathology 
observed in CTE is typical of the tauopathies but with some distinct differences 
compared to ADNC alone. The spread of pathogenic tau along anatomical pathways 
could be a factor in the pathogenesis of the disease.  
 
Key Words: Chronic traumatic encephalopathy (CTE); Alzheimer’s disease 
neuropathologic change (ADNC); Tauopathy; Neurofibrillary tangle; Spatial pattern; 
Spatial correlation 
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Introduction 
 
Chronic traumatic encephalopathy (CTE) is a neurodegenerative disorder which may 
result from repetitive brain injury (Geddes et al 1999, Jordan 2013). It has been 
recorded in association with a variety of contact sports including boxing, American 
football, hockey, and wrestling (Maroon et al. 2015) and has also been reported in 
military veterans exposed to blast shock waves from explosive devices (Goldstein et 
al. 2012; McKee et al. 2013, 2014, 2015; Shetty et al. 2014).  
 
Clinical symptoms of CTE include impairment of memory and executive function, 
behavioural change, and motor dysfunction (Saing et al. 2012). Neuropathologically, 
CTE cases exhibit reduced gray matter volume in several brain regions, most 
prominently affecting frontal and anterior temporal lobes and the limbic and striato-
nigral systems associated with enlargement of the lateral and third ventricles (McKee 
et al. 2013, 2016). A spectrum of tau-immunoreactive pathology is present including 
neurofibrillary tangles (NFT) (Kieman et al. 2015; McKee et al. 2013), neuropil 
threads (NT), dot-like grains (DLG) (Armstrong et al. 2016), and astrocytic tangles 
(AT) (Saing et a.l 2012; Stein et al. 2014, 2015), a proportion of the latter resembling 
thorn-shaped astrocytes observed in other disorders (Armstrong et al. 1999, 2000, 
2007a). The isoform profile and phosphorylation state of tau in CTE is similar to that 
of Alzheimer’s disease (AD) (Schmidt et al. 2001) in that both three-repeat (3R) and 
four-repeat (4R) tau are present in equal ratios. In a proportion of cases, AD 
neuropathologic change (ADNC), viz., beta-amyloid (A) deposits and neuritic 
plaques (NP) are present (Graham et al. 1995; Johnson et al 2012, Stein et al. 2015). 
In addition, oligodendroglial inclusions (GI) are occasionally present in CTE together 
with low densities of abnormally enlarged neurons (EN) and vacuolation (Armstrong 
et al. 2016). 
 
In several tauopathies, e.g., AD (Armstrong 1993a), Pick’s disease (PiD) (Armstrong 
et al. 1998a), CBD (Armstrong and Cairns 2009), and PSP (Armstrong et al. 2007b), 
tau-immunoreactive inclusions in the cortex are frequently clustered within particular 
laminae, the clusters being regularly distributed parallel to the pia mater. This 
clustering pattern could result from the degeneration of neuroanatomical pathways 
(Armstrong et al 2001) and a consequence of the ‘prion-like’ behaviour of 
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pathological tau which spreads among brain regions along anatomical pathways 
(Goedert 2010; Armstrong and Cairns 2012). Hence, to determine whether similar 
clustering was present in CTE, the spatial patterns of the tau-immunoreactive 
pathologies were studied in the cortex and hippocampus in 11 cases of the disease and 
compared with seven cases of ADNC without CTE.  
 
Materials and Methods 
 
Cases 
 
CTE cases (N = 11, mean age 70 years, SD = 6.42) (Table 1) and ADNC cases not 
associated with CTE (n = 7, mean age 79 years, SD = 8.83) (Table 1) were obtained 
from Boston University’s CTE centre (VA-BU-CLF Brain Bank). With the exception 
of one case, a boxer for 26 years (Case C), all individuals with CTE had played 
American football, career durations being in the range 11-24 years. In addition, all 
patients had suffered at least one traumatic episode resulting in concussion, some with 
accompanying loss of consciousness, the majority of cases having experienced 
multiple episodes of trauma during their careers. All cases were diagnosed according 
to criteria published by McKee et al. (2016): (1) foci of perivascular NFT, AT, and 
DLG irregularly distributed in cortex with a predilection for the sulcal depths, (2) 
NFT in superficial laminae II/III especially in temporal cortex, and (3) clusters of 
subpial AT in the cortex as an additional finding. Cases were classified according to 
the staging system suggested by McKee et al (2015). Hence, stage 1 cases were 
characterized by discrete foci of tau pathology in the cerebral cortex most commonly 
in superior or lateral frontal cortex, stage 2 by multiple foci of tau pathology with 
evidence of spread to superficial adjacent cortex, the medial temporal lobe being 
largely spared, stage 3 by substantial spread of pathology in frontal, insular, temporal, 
and parietal cortex with pathology also affecting the amygdala, hippocampus, and 
entorhinal cortex, and stage 4 by widespread severe tau pathology affecting most 
regions of the cerebral cortex and medial temporal lobe with the possible exception of 
the occipital cortex. The majority of the eleven CTE cases studied were classified as 
stage 3 or 4. The neuropathology of CTE frequently overlaps with that of common 
neurodegenerative diseases such as AD (Maroon et al. 2013) (Table 1). Hence, one 
case was diagnosed as ‘pure’ CTE without any associated co-pathology but the 
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remaining cases exhibited one or more co-pathologies most commonly ADNC (N = 
7), primary age-related tauopathy (PART) (N = 2) (Dickson 2009; Crary et al. 2014), 
hippocampal sclerosis (HS) (N = 4) (Josephs et al. 2006), TDP-43 proteinopathy (N = 
8), or argyrophilic grain disease (AGD) (N = 1). National Institute on Aging-
Alzheimer’s (NIA-AA) association guidelines ‘ABC’ scores of the CTE cases equated 
to ‘not AD’ - ‘intermediate’ level of AD (Hyman et al 2012). PART is a new 
neuropathological entity characterized by tau pathology typically in the temporal lobe 
and is associated with aging independent of amyloid pathology (Dickson 2009; Crary 
et al. 2014). Hence, cases diagnosed as CTE were also designated as having PART 
according to the following criteria: (1) a diffuse cerebral atrophy was present most 
severe in the temporal lobe, (2) NFT were present in the medial temporal lobe, 
hippocampus, and amygdala, (3) extracellular ‘ghost’ tangles were present, and (4) 
sparse diffuse A deposits were present but with few NP (Dickson 2009; Crary et al 
2014). 
 
Neuropathology 
 
These studies were approved by the local Institute Review Board of Boston 
University and were carried out according to the 1995 Declaration of Helsinki (as 
modified in Edinburgh, 2000). After death, the next-of-kin provided written consent 
for brain removal and retention for research studies. Brains were fixed in 10% neutral 
buffered formalin for at least two weeks, paraffin-embedded, and sections cut at 6 
m. For this study, blocks were taken from: (1) frontal lobe to study the superior 
frontal gyrus (SFG) (BA 8,6), (2) temporal pole (TP) (BA 38,36), and (3) temporal 
lobe to study the superior temporal gyrus (STG) (BA 22), (4) entorhinal cortex (EC) 
(BA 28) at the level of the amygdala, and (5) medial temporal lobe (MTL) to study 
the subiculum, sector CA1 of the hippocampus (HC), and dentate gyrus (DG). 
Histologic stains included luxol fast blue in combination with hematoxylin and eosin 
(LHE) and a modified Bielschowsky silver impregnation. Immunohistochemistry was 
performed using the following antibodies: A42 (AB5078P; EMD Millipore, 
Billerica, MA, USA; 1:2000), phosphorylated tau (AT8, Pierce Endogen, Rockford, 
IL, USA; 1:2000), and phosphorylated TDP-43 (pTDP-43, pS409/410 mouse 
monoclonal; Cosmo Bio Co Ltd, Tokyo, Japan; 1:2000). Each slide was digitally 
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scanned and subsequently visualized on a PC using Aperio Image-Scope Software 
(Leica Biosystems Inc. Buffalo Grove, IL, USA) (Armstrong et al. 2016).  
 
Morphometry 
 
In each cortical gyrus (SFG, TP, STG, EC), variation in the densities of NFT, NT, 
DLG, AT, and NP were measured from crest to sulcus parallel to the pia mater, using 
250 x 50 µm sample fields arranged contiguously (Armstrong 2003a; Armstrong et al. 
2016). Sample fields were superimposed over the image using either the draw or 
rectangle options (minimum N = 32 fields) (Armstrong et al. 2016). The sample fields 
were located in the upper (approximating to laminae II/III) cortex, the region where 
the densest tau-pathology is observed in CTE (McKee et al. 2014; Armstrong et al. 
2016). The short edge of the sample field was orientated parallel with the pia mater 
and aligned with guidelines drawn on the section. Histological features were also 
studied in the subiculum (N = 16 fields) and in sector CA1 (N = 16 fields) the short 
dimension of the sample field being aligned with the alveus. In the DG, the pathology 
was quantified in the molecular and granule cell layer (N = 32 fields). NFT were 
present in the cytoplasm of larger cells with a distinct region of haematoxylin-positive 
cytoplasm while AT were either distinct cytoplasmic inclusions associated with 
larger, pale nuclei or resembled thorn-shaped astrocytes. NT were thread-like 
structures some of which were serpiginous, while small circular structures were 
identified as DLG (Armstrong et al. 2016). To quantify the frequency of the larger 
blood vessels in CTE, a dashed line was drawn across the image within each sample 
field parallel to the longer dimension of the field at a random location using the 
negative pen tool (F3). The frequency of contacts between the dashed lines and all 
major blood vessel profiles (>10 m in diameter) within the sample field was 
recorded (Armstrong, 2006a). 
 
Data analysis 
 
To determine the degree of clustering of the tau pathology, the data were analyzed by 
spatial pattern analysis (Armstrong 1993b, 1997, 2006b). Departure from a random 
distribution can be measured by calculating the variance/mean (V/M) ratio of the 
counts of individual histological features in the contiguous sample fields. If a feature 
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is randomly distributed, the number of samples containing 0, 1, 2, 3 … n, inclusions 
should correspond to a Poisson distribution and the V/M ratio should approximate to 
unity. A V/M ratio less than unity indicates a regular distribution and greater than 
unity a clumped or clustered distribution. If a feature is clustered, the mean size and 
distribution of the clusters can be obtained from counts of lesions in adjacent sample 
fields added together successively to provide data for increasing field sizes, e.g., 200 
x 1000 µm, 400 x 1000 µm, 800 x 1000 µm etc., up to a size limited by the total 
length of strip sampled. The V/M ratio is calculated at each field size. A V/M peak 
indicates the presence of regularly spaced clusters and location of the peak indicates 
mean cluster size, statistical significance of a V/M peak being tested using the ‘t’ 
distribution (Armstrong 1997). The frequencies of the different clustering patterns 
were compared using 2 contingency tables: (1) between cerebral cortex and 
subiculum/CA1/DG, (2) among different tau-immunoreactive pathologies, and (3) 
among cases. Spatial correlations between cluster size of the pathology and frequency 
of blood vessel contacts were tested using Pearson’s correlation coefficient (‘r’) 
(Armstrong 2003b).  
 
Results  
 
Fig 1 shows the typical tau-immunoreactive pathology in the TP of a case of CTE 
(Case A). Clusters of NFT are present in the upper laminae, apparently regularly 
distributed parallel to the pia mater, and are accompanied by DN and more widely 
distributed DLG.  
 
Examples of the spatial pattern analysis of the NFT, NT, and DLG in a single region 
of a case of CTE (Case 6, EC) are shown in Fig 2. NFT exhibited a V/M peak at a 
field size of 50 m suggesting a regular distribution of clusters of NFT, 50 m in 
diameter, distributed parallel to the pia mater. NT exhibited two V/M peaks at field 
sizes of 100 m and 400 m suggesting a regular distribution of clusters 50 m in 
diameter, aggregated into larger ‘superclusters’ 400 m in diameter. The DLG 
exhibited an increasing V/M with field size without reaching a peak, suggesting a 
large cluster of DLG, of at least 800 m in diameter. 
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The frequency of the different spatial patterns exhibited by the tau-immunoreactive 
pathology in all CTE regions and cases examined are summarized in Table 2. All 
features of the pathology were clustered, and in a proportion of regions, the clusters 
were regularly distributed parallel to the tissue boundary. This spatial pattern was 
observed in the cortex and in the subiculum/sector CA1/DG respectively in 15/42 
(36%) and 13/32 (41%) analyses of NFT, 26/40 (65%) and 16/32 (50%) of NT, 21/43 
(49%) and 22/33 (67%) of DLG, 7/28 (25%) and 1/5 (20%) of AT, and 1/3 (33%) and 
0/1 (0%) of NP. In a subset of cortical regions, the dimensions of the clusters were in 
the range 400 – 800 m. The frequencies of the different clustering patterns were 
similar in cerebral cortex and subiculum/CA1/DG. However, there were significant 
differences among tau pathologies, the NT and DLG exhibiting a greater frequency of 
regularly distributed clusters than the NFT. Clustering patterns were similar in the two 
cases with relatively little co-pathology, viz. ‘pure’ CTE (Case K) and CTE/PART 
(Case H) compared with all remaining cases and in those cases with and without 
associated ADNC or TDP-43 proteinopathy. No significant correlations were present 
between estimated cluster size and disease duration or sporting career length. In 
addition, there were no significant correlations between cluster sizes of the NFT, NT, 
and DLG and CTE stage. However, there were also positive correlations between the 
cluster size of the pathology and ADNC stage including NT in the SFG with ‘C’ (NP) 
stage (r = 0.77, P < 0.05) and between DLG in the EC with ‘B’ (NFT) stage (r = 0.65, 
P < 0.05). 
 
Similar spatial patterns of the NFT and NP were observed in cases of ADNC without 
CTE (Table 3). Hence, regular spaced clusters of the pathology were observed in the 
cortex and in the subiculum/sector CA1/DG respectively in 22/30 (73%) and 9/13 
(69%) analyses of NFT and 12/26 (46%) and 11/20 (55%) of NP. In addition, there 
were significant differences in spatial pattern between CTE and ADNC cases with 
AD cases having a significantly more clustered and CTE more frequent random and 
uniform distributions of the tau pathology (NFT 2  = 19.29, P > 0.001); NP 2 = 
9.80, P < 0.05). 
.  
Spatial correlations between the densities of tau-immunoreactive pathology and 
frequency of contacts with major blood vessel profiles in CTE are shown in Table 4. 
Significant positive spatial correlations with blood vessels were infrequent and 
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present in 14/132 (11%) of analyses, slightly better than chance, and included either 
the DN or DLG. Hence, in the majority of regions examined, clustering of the tau-
immunoreactive pathology along the gyrus from crest to sulcus was not spatially 
correlated with the presence of larger blood vessel profiles. 
 
Discussion 
 
Considerable variations in density of the tau-immunoreactive pathology were evident 
in both CTE and ADNC cases parallel to the tissue boundary in the upper laminae of 
the cortex and in the subiculum, sector CA1, and DG. Hence, caution is required in 
the interpretation of results especially of the CTE case given the large range of onset 
and trauma present. Frequently, the pathological features formed clusters and in a 
proportion of regions, the clusters were regularly distributed parallel to the pia mater, 
alveus, or edge of the DG granule cell layer. Similar clustering patterns were observed 
in ADNC cases without CTE and have also been reported previously in various 
tauopathies, e.g., NFT in AD (Armstrong 1993a), Pick bodies (PB) in PiD 
(Armstrong et al 1998a), neuronal cytoplasmic inclusions (NCI) in CBD (Armstrong 
et al 2009), and NFT in progressive supranuclear palsy (PSP) (Armstrong et al 
2007b). In addition, the clustering patterns were similar in the two CTE cases with 
relatively little co-pathology (CTE, CTE/PART), compared with the remaining cases 
with significant co-pathologies, and in cases with and without associated ADNC or 
TDP-43 proteinopathy. Hence, regular clustering of the tau-immunoreactive 
pathology is a feature of CTE and does not appear to depend on the presence of 
ADNC or TDP-43 co-pathology. 
 
Although the spatial patterns of the tau pathology are similar in CTE cases with and 
without ADNC, there are differences when compared to ADNC cases without CTE.  
Hence, NFT and NP were more frequently randomly or uniformly distributed in CTE 
but present more frequently in well-defined clusters in ADNC. These results suggest 
that the spatial pattern of the tau pathology in CTE with or without associated ADNC 
is different to that of ADNC alone. Hence, the presence of CTE makes a significant 
contribution to the tau pathology of these complex cases. 
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Previous studies of pathological features in a variety of disorders suggest two 
explanations for clustering especially when clusters are regularly spaced. First, A 
deposits in AD (Armstrong et al 1998b, Armstrong 2006a) and prion protein (PrPsc) 
deposits in Creutzfeldt-Jakob disease (CJD) (Armstrong 2009) are clustered around 
the major blood vessels. In the cortex, larger arterioles penetrate the pia at regular 
intervals and then extend vertically through the laminae reaching a maximum density 
in cortical laminae IV (Bell and Ball 1990) and giving rise to a more or less regular 
distribution of vessels in the upper laminae (Armstrong 2006a). Clustering of protein 
deposits around these vessels in AD suggests an impaired blood brain barrier could be 
involved in their formation. The present data, however, suggest little overall spatial 
correlation between the tau pathology and the location of major blood vessel profiles 
from the crest of the gyrus to the sulcus or in the subiculum, sector CA1, or DG. 
There may be two explanations for the overall lack of correlation. First, spatial 
correlations with blood vessels may be specific to certain brain regions. Hence, tau 
pathology in CTE frequently occurs at higher density in the sulcal depths compared 
with the crests and upper sides of the gyri (Kieman et al 2015, McKee et al 2015, 
Armstrong et al 2016). These differences in density are often most marked in frontal 
cortex where in some cases a marked perivascular distribution of NFT and especially 
AT are present (McKee et al 2013, 2015). Second, clustering of the tau-
immunoreactive pathology around larger blood vessels could be characteristic of the 
early stages of the pathology in CTE. As the disease develops, however, the pathology 
spreads to affect capillaries located between the major blood vessel profiles thus 
reducing the chance of detecting a spatial correlation due to the abundance of both tau 
inclusions and capillary profiles (Kawai et al 1990, Luthert and Williams 1991, 
Armstrong 2006a, 2009). 
 
Second, as in other tauopathies, clustering of the tau-immunoreactive pathology could 
be related to the degeneration of specific anatomical pathways. First, in a significant 
proportion of cortical gyri, the tau pathology, especially the NT, and DLG, was 
present in regularly distributed clusters. Many features of cortical architecture are 
similarly clustered, e.g., the cells of origin of the cortico-cortical pathways are 
clustered and occur in bands regularly distributed along the cortex parallel to the pia 
mater (Hiorns et al 1991). Second, individual bands of cells associated with the 
cortico-cortical pathways are approximately 400 – 1000 m in width depending on 
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region, and traverse the laminae in columns (Hiorns et al 1991, DeLacoste and White 
1993). In a proportion of gyri, the estimated widths of the clusters of tau pathology, 
measured parallel to the pia mater, were within this size range. Third, anatomically 
connected regions exhibited similar regularly distributed patterns of clusters e.g., in 
the EC and DG granule cells suggesting an association of the pathology and 
degeneration of the perforant path (Armstrong et al 2000). Hence, as in the other 
tauopathies, clustering of the tau pathology in CTE could be the result of the 
hypothesised ‘prion-like’ behaviour of tau and it’s spread through the brain via cell to 
cell transfer (Goedert et al 2010). Head trauma could therefore initiate damage to 
blood vessels, especially in sulci, resulting in cellular degeneration close to blood 
vessels and the formation of foci of pathogenic tau. Pathogenic tau could then spread 
through the brain along anatomical pathways as hypothesized in other tauopathies 
(Goedert et al 2010, Armstrong and Cairns 2012).  
 
In conclusion, the tau-immunoreactive pathology of CTE exhibits a clustering pattern 
typical of the tauopathies in which the clusters are often regularly distributed parallel 
to the tissue boundary. Similar types of spatial patterns of NFT and NP were also 
present in ADNC without CTE, but with some differences when compared with CTE. 
Although a marked perivascular distribution of the tau pathology can be observed 
affecting individual large vessels, especially in sulci; overall, the clustering patterns 
observed were not spatially related to the larger blood vessel profiles. Hence, local 
blood vessel damage in CTE could result in the formation of pathologic tau in regions 
close to blood vessels which then exhibits further neuroanatoamical spread to affect a 
range of brain areas. 
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Table 1 Demographic and neuropathology features of the chronic traumatic 
encephalopathy (CTE) cases including National Institute on Aging-Alzheimer’s 
association guidelines NIA-AA) ‘ABC’ scores (A = Amyloid-beta, B = 
Neurofibrillary tangles, C = Neuritic plaques) 
_____________________________________________________________________ 
Case Age* Onset Trauma Career  Pathology CTE  A B C
 (yrs) (yrs)   length   stage 
 (yrs) 
_____________________________________________________________________ 
A 75 65 10/2  18 CTE,ADNC, 3 A3 B2 C1 
HS,TDP-43 
B 70 66 10/1  11 CTE,ADNC, 3 A0 B2 C0 
TDP-43 
C 60 55 1/1  26 CTE,HS, 2 A0 B1 C0 
TDP-43 
D 65 56 -  19 CTE,ADNC, 4 A2 B2 C1 
HS,TDP-43 
E 70 61 3/0  21 CTE,TDP-43, 3 A0 B1 C0 
PART, AGD 
F 80 67 F  12 CTE,ADNC, 4 A2 B2 C0 
HS,TDP-43 
G 80 38 -  18 CTE,ADNC, 4 A3 B2 C1 
TDP-43 
H 65 55 50/1  17 CTE/PART 3 A0 B2 C0 
I 70 61 10/1  19 CTE,ADNC, 3 A2 B1 C1 
TDP-43 
J 60 54 25/1  21 CTE,ADNC, 4 A3 B2 C0 
TDP-43 
K 70 45 F  20 CTE  4 A0 B2 C0 
 
ADNC 
A 90 85 -  - ADNC   A3 B2   C1 
B 70 67 -  - ADNC/TDP-43 A2 B2 C1 
C 80 75 -  - ADNC/AGD  A0 B1 C0 
 20 
D 85 73 -  - ADNC/VD  A3 B2 C1 
E 90 81 -  - ADNC/TDP-43 A2 B1 C1 
F 70 56 -  - ADNC   A1 B2 C1 
G 70 62 -  - ADNC   A3 B2 C1 
_____________________________________________________________________ 
Abbreviations: F = Frequent, ADNC = Alzheimer’s disease neuropathologic change, 
HS = Hippocampal sclerosis, TDP-43 = Transactive response (TAR) DNA-binding 
protein of 43kDa, PART = Primary age-related tauopathy, AGD = Argyrophilic grain 
disease, VD = Vascular disease, * Age rounded to nearest 5-year age interval to 
protect subject identities 
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Table 2 Frequency of spatial patterns (R = Random distribution, Reg = Regular or 
uniform distribution, Reg Clusters = Regularly distributed clusters of inclusions) of 
the tau-immunoreactive neurofibrillary tangles (NFT), dystrophic neurites (DN), dot-
like grains (DLG), astrocytic tangles (AT), and neuritic plaques (NP) in the cerebral 
cortex and hippocampus in 11 cases of chronic traumatic encephalopathy (CTE). 
Figures in parentheses in column 5 indicate percentage of regions investigated in 
which cluster size was in the range 400 – 800 m. 
_____________________________________________________________________ 
Pathology Region  R   Reg Reg Clusters Large clusters 
_____________________________________________________________________ 
NFT  Cortex  11  11 15 (6)  5 
  Sub/HC/DG 5  7 13 (0)  7 
NT  Cortex  3  1 26 (12)  10 
  Sub/HC/DG 5  1 16 (0)  10 
DLG  Cortex  2  0 21 (4)  20 
  Sub/HC/DG 0  1 22 (0)  10 
AT  Cortex  13  5 7 (6)  3 
  Sub/HC/DG 4  0 1 (0)  0 
NP  Cortex  2  0 1 (0)  0 
  Sub/HC/DG 0  1 0  0 
_____________________________________________________________________ 
Chi-square (2) contingency tests: Cortex vs Sub/HC/DG NFT 2  = 6.68 (4DF, P > 
0.05), NT 2 = 10.72 (4DF, P < 0.05), DLG 2 = 21.25 (4DF, P < 0.001), AT 2  = 
3.80 (4DF, P > 0.05); Among pathologies: Cortex 2 = 71.20 (16DF, P < 0.001), 
HC/Sub 2 = 43.82 (12DF, P < 0.001); Among cases: CTE + CTE/PART compared 
with remaining cases NFT 2  = 0.59 (3DF, P > 0.05), NT 2 = 4.73 (3DF, P > 0.05), 
DLG 2 = 1.29 (3DF, P > 0.05), AT 2  = 4.68 (3DF, P > 0.05); CTE cases with or 
without ADNC: NFT 2  = 3.53 (3DF, P > 0.05), NT 2 = 2.94 (3DF, P > 0.05), DLG 
2 = 1.73 (3DF, P > 0.05), AT 2  = 1.73 (3DF, P > 0.05); CTE cases with and 
without TDP-43 NFT 2  = 0.18 (3DF, P > 0.05), NT 2 = 1.62 (3DF, P > 0.05), DLG 
2 = 1.35 (3DF, P > 0.05), AT 2  = 6.28 (3DF, P > 0.05) 
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Table 3 Frequency of spatial patterns (R = Random distribution, Reg = Regular or 
uniform distribution, Reg Clusters = Regularly distributed clusters of inclusions) of 
the tau-immunoreactive neurofibrillary tangles (NFT) and neuritic plaques (NP) in the 
cerebral cortex and hippocampus in seven cases of Alzheimer’s disease 
neuropathologic change (ADNC) without CTE. Figures in parentheses in column 5 
indicate percentage of regions investigated in which cluster size was in the range 400 
– 800 m. 
_____________________________________________________________________ 
Pathology Region  R   Reg Reg Clusters Large clusters 
_____________________________________________________________________ 
NFT  Cortex  1  0 22 (12)  7 
  Sub/HC/DG 3  0 9 (0)  1 
NP  Cortex  1  1 12 (8)  12 
  Sub/HC/DG 3  1 11 (0)  5 
_____________________________________________________________________ 
Chi-square (2) contingency tests: CTE vs ADNC NFT 2 = 19.29 (3DF, P > 0.001), 
NP 2 = 9.80 (3DF, P < 0.05) 
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Table 4 Frequency of significant spatial correlations between the tau-immunoreactive 
neurofibrillary tangles (NFT), dystrophic neurites (DN), dot-like grains (DLG), 
astrocytic tangles (AT), and neuritic plaques (NP) and larger blood vessel profiles (> 
10 m diameter) along the sides of gyri in the upper laminae of the cerebral cortex in 
11 cases of chronic traumatic encephalopathy (CTE). 
_____________________________________________________________________ 
Correlation  NFT  NT  DLG  AT   NP 
_____________________________________________________________________ 
Positive  2  3  9  0  0 
 
Negative  2  0  0  0  0 
 
Not significant 40  41  35  37  5 
 
_____________________________________________________________________ 
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Legends to figure 
 
Fig 1 The tau-immunoreactive pathology at the temporal pole (TP) of a case of 
chronic traumatic encephalopathy (CTE) (Case A) showing clusters of neurofibrillary 
tangles (NFT) apparently regularly distributed parallel to the pia mater, dystrophic 
neurites (DN), and widespread dot-like grains (DLG), tau immunohistochemistry 
(AT8), haematoxylin 
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Fig 2 Examples of the spatial patterns exhibited by neurofibrillary tangles (NFT), 
dystrophic neurites (DN), and dot-like grains (DLG) in a case  of chronic traumatic 
encephalopathy (CTE) (Case 6, entorhinal cortex) 
 
 
 
 
 
 
 
